Rocket Pharmaceuticals is trading 6.8% up at $3.32 in pre-market action, following last Friday’s close at $3.11.

  • There are currently no fresh company-specific headlines, earnings reports, or analyst calls clearly tied to this move.
  • Given the lack of direct news and mildly positive futures, the gain may reflect general risk-on sentiment rather than a company-specific development.